United Airlines will offer its customers rapid-response coronavirus tests at the airport, beginning on Oct. 15 with its Hawaii-bound customers from San Francisco.
Passengers will shoulder the cost of the be $250 swab test.
GoHealth Urgent Care and Dignity Health will administer the molecular test before security checkpoints and would make the results ready after 15 minutes.
The international terminal, where airport employees were tested, would be the testing site.
United’s Hawaii-bound customers from San Francisco can also opt for an $80 mail-in test to be conducted at home.
The start of the service was scheduled at the date when Hawaii is set to lift a two-week quarantine requirement on arriving travelers testing negative for Covid-19 within 72 hours of their departure.
Janet Lamkin, United’s California president, noted that the airline is interested in offering the service to other destinations.
Airlines have been urging governments worldwide to consider Covid-19 testing for passengers before international flights as an alternative to travel bans.


U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation
Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years
One Percent Rule Checklist For Safer Forex Trading Risk
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production
Tesla Revives Dojo Supercomputer Project With AI5 Chip at the Core
Baidu Shares Rise in Hong Kong After Apollo Go Robotaxi Launch in Abu Dhabi
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision
Trump Criticizes NYSE Texas Expansion, Calls Dallas Exchange a Blow to New York
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny
Proposed Rio Tinto–Glencore Merger Faces China Regulatory Hurdles and Asset Sale Pressure
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 



